To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of new antimicrobial therapeutics developed by SMEs.
The United Kingdom’s 2024 to 2029 national action plan (NAP) to confront antimicrobial resistance (AMR) includes a commitment to work across sectors to develop new antimicrobials. The NAP also acknowledges the potential of alternative therapies, such as b...
Antimicrobials: Small Businesses